}

Sabaa Pharmaceutical’s profits drop 84% YoY in 9 months

Updated 11/1/2026 1:52:00 PM
Sabaa Pharmaceutical’s profits drop 84% YoY in 9 months

Arab Finance: Sabaa International for Pharmaceutical and Chemical Industry posted an 84.05% year-on-year (YoY) decline in net profit after tax for the first nine months of 2026, according to the financial results.

The company’s net profit reached EGP 2.668 million at the end of September 2026, down from EGP 16.734 million a year earlier.

Earnings per share (EPS) plunged to EGP 0.011 from EGP 0.067, while revenues fell to EGP 27.806 million from EGP 41.967 million.

In the January-June 2026 period, the EGX-listed firm generated net profit after tax of EGP 2,910, compared to EGP 11.933 million in the first half (H1) of 2025.

Related News